Cargando…

Time to Diagnosis in Young Onset Alzheimer’s Disease: A Population-Based Study from Central Norway

BACKGROUND: Young onset dementia is associated with a longer time to diagnosis compared to late onset dementia. Earlier publications have indicated that atypical presentation is a key contributing factor to the diagnostic delay. Our hypothesis was that even the most common presentation of Alzheimer’...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kvello-Alme, Marte, Bråthen, Geir, White, Linda R., Sando, Sigrid Botne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8461696/ https://www.ncbi.nlm.nih.gov/pubmed/34120901 http://dx.doi.org/10.3233/JAD-210090

Ejemplares similares

Incidence of Young Onset Dementia in Central Norway: A Population-Based Study
por: Kvello-Alme, Marte, et al.
Publicado: (2020)

The Prevalence and Subtypes of Young Onset Dementia in Central Norway: A Population-Based Study
por: Kvello-Alme, Marte, et al.
Publicado: (2019)

The Amyloid, Tau, and Neurodegeneration (A/T/N) Classification Applied to a Clinical Research Cohort with Long-Term Follow-Up
por: Grøntvedt, Gøril Rolfseng, et al.
Publicado: (2020)

Association of Klotho Protein Levels and KL-VS Heterozygosity With Alzheimer Disease and Amyloid and Tau Burden
por: Grøntvedt, Gøril Rolfseng, et al.
Publicado: (2022)

Cerebrospinal Fluid Aβ43 Is Reduced in Early-Onset Compared to Late-Onset Alzheimer’s Disease, But Has Similar Diagnostic Accuracy to Aβ42
por: Lauridsen, Camilla, et al.
Publicado: (2017)

Experiential seizures related to the hippocampal-parahippocampal spatial representation system
por: Revdal, Eline, et al.
Publicado: (2020)

Plasma apolipoprotein E levels in longitudinally followed patients with mild cognitive impairment and Alzheimer’s disease
por: Giannisis, Andreas, et al.
Publicado: (2022)

APOE ε4 lowers age at onset and is a high risk factor for Alzheimer's disease; A case control study from central Norway
por: Sando, Sigrid B, et al.
Publicado: (2008)

Assessment of kallikrein 6 as a cross-sectional and longitudinal biomarker for Alzheimer’s disease
por: Patra, Kalicharan, et al.
Publicado: (2018)

Alpha-synuclein measured in cerebrospinal fluid from patients with Alzheimer’s disease, mild cognitive impairment, or healthy controls: a two year follow-up study
por: Berge, Guro, et al.
Publicado: (2016)

Safety and efficacy of plasma transfusion from exercise-trained donors in patients with early Alzheimer’s disease: protocol for the ExPlas study
por: Tari, Atefe R, et al.
Publicado: (2022)

Cerebrospinal Fluid Levels of Amyloid Beta 1–43 in Patients with Amnestic Mild Cognitive Impairment or Early Alzheimer’s Disease: A 2-Year Follow-Up Study
por: Lauridsen, Camilla, et al.
Publicado: (2016)

Current and Future Prevalence Estimates of Mild Cognitive Impairment, Dementia, and Its Subtypes in a Population-Based Sample of People 70 Years and Older in Norway: The HUNT Study
por: GjØra, Linda, et al.
Publicado: (2021)

Meta-analysis of Alzheimer’s disease on 9,751 samples from Norway and IGAP study identifies four risk loci
por: Witoelar, Aree, et al.
Publicado: (2018)

Cerebrospinal Fluid Levels of Amyloid Beta 1-43 Mirror 1-42 in Relation to Imaging Biomarkers of Alzheimer’s Disease
por: Almdahl, Ina S., et al.
Publicado: (2017)

Detecting At-Risk Alzheimer’s Disease Cases
por: Fladby, Tormod, et al.
Publicado: (2017)

Apolipoprotein E ε2 genotype delays onset of dementia with Lewy bodies in a Norwegian cohort
por: Berge, Guro, et al.
Publicado: (2014)

The relevance of cerebrospinal fluid α-synuclein levels to sporadic and familial Alzheimer’s disease
por: Twohig, Daniel, et al.
Publicado: (2018)

A multinational study distinguishing Alzheimer's and healthy patients using cerebrospinal fluid tau/Aβ42 cutoff with concordance to amyloid positron emission tomography imaging
por: Mo, Yi, et al.
Publicado: (2017)

Factors associated with emergency-onset diagnosis, time to treatment and type of treatment in colorectal cancer patients in Norway
por: Nilssen, Yngvar, et al.
Publicado: (2021)

Late Onset Myasthenia Gravis Is Associated with HLA DRB1*15:01 in the Norwegian Population
por: Maniaol, Angelina H., et al.
Publicado: (2012)

Cognitive and Emotional Impairment after Minor Stroke and Non-ST-Elevation Myocardial Infarction (NSTEMI): A Prevalence Study
por: Morsund, Åse Hagen, et al.
Publicado: (2019)

Health disparities, and health behaviours of older immigrants & native population in Norway
por: Qureshi, Samera Azeem, et al.
Publicado: (2022)

Job Satisfaction Among Psychomotor Physiotherapists in Norway
por: Rosenberg, Marte Kimo, et al.
Publicado: (2022)

Time from Symptom Debut to Dementia Assessment by the Specialist Healthcare Service in Norway
por: Helvik, Anne-Sofie, et al.
Publicado: (2018)

Leisure-Time Physical Activity Is Associated With Reduced Risk of Dementia-Related Mortality in Adults With and Without Psychological Distress: The Cohort of Norway
por: Zotcheva, Ekaterina, et al.
Publicado: (2018)

Electrophysiological Characterization of Networks and Single Cells in the Hippocampal Region of a Transgenic Rat Model of Alzheimer’s Disease
por: Heggland, Ingrid, et al.
Publicado: (2019)

Changes in BMI-distribution from 1966–69 to 1995–97 in adolescents. The Young-HUNT study, Norway
por: Bjørnelv, Sigrid, et al.
Publicado: (2007)

Brain Amyloid in Sporadic Young Onset Alzheimer’s Disease
por: Panegyres, Peter K., et al.
Publicado: (2023)

The potential spread of severe footrot in Norway if no elimination programme had been initiated: a simulation model
por: Grøneng, Gry M, et al.
Publicado: (2015)

An assessment of air passenger confidence a year into the COVID-19 crisis: A segmentation analysis of passengers in Norway
por: Budd, Thomas, et al.
Publicado: (2021)

Quantitative EEG findings in patients with acute, brief depression combined with other fluctuating psychiatric symptoms: a controlled study from an acute psychiatric department
por: Bjørk, Marte Helene, et al.
Publicado: (2008)

Screening for Alzheimer’s Disease: Cognitive Impairment in Self-Referred and Memory Clinic-Referred Patients
por: Kirsebom, Bjørn-Eivind, et al.
Publicado: (2017)

Violacein-Producing Collimonas sp. from the Sea Surface Microlayer of Costal Waters in Trøndelag, Norway
por: Hakvåg, Sigrid, et al.
Publicado: (2009)

Lamb Performance on Island Pastures in Northern Norway
por: Lind, Vibeke, et al.
Publicado: (2020)

Improving public cancer care by implementing precision medicine in Norway: IMPRESS-Norway
por: Helland, Åslaug, et al.
Publicado: (2022)

Streptococcus dysgalactiae Bloodstream Infections, Norway, 1999–2021
por: Oppegaard, Oddvar, et al.
Publicado: (2023)

HINT1 neuropathy in Norway: clinical, genetic and functional profiling
por: Amor-Barris, Silvia, et al.
Publicado: (2021)

Healthcare utilization prior to a diagnosis of young-onset Alzheimer’s disease: a nationwide nested case–control study
por: Damsgaard, Line, et al.
Publicado: (2023)

Monitoring young lifestyles (MyLife) - a prospective longitudinal quantitative and qualitative study of youth development and substance use in Norway
por: Brunborg, Geir Scott, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_sit7vo9sm5e97p8r2p85nnra0n